| HOME >> BIOLOGY >> TECHNOLOGY |
GROSS PROFIT 2,312,020 1,687,578
OPERATING EXPENSES
Research and development 88,392 100,112
Selling, general and administrative 812,508 643,846
Total operating expenses 900,900 743,958
INCOME FROM OPERATIONS 1,411,120 943,620
OTHER INCOME (EXPENSE), NET 5,983 (2,972)
INCOME BEFORE INCOME TAXES 1,417,103 940,648
AND MINORITY INTEREST
PROVISION FOR INCOME TAXES 268,767 199,959
INCOME BEFORE MINORITY INTEREST 1,148,336 740,689
MINORITY INTEREST 27,477 23,032
NET INCOME 1,175,813 763,721
OTHER COMPREHENSIVE INCOME
Foreign currency translation adjustment 1,327,166 256,489
COMPREHENSIVE INCOME $ 2,502,979 $ 1,020,210
EARNINGS PER SHARE
Basic $ 0.08 $ 0.08
Diluted $ 0.08 $ 0.06
WEIGHTED AVERAGE SHARES OUTSTANDING
Basic 15,029,865 9,152,458
Diluted 15,339,834 12,808,226
CHINA MEDICINE CORPORATION AND SUBSIDIARIES
CONSOLIDATED BALANCE SHEETS
AS OF MARCH 31, 2008 AND DECEMBER 31, 2007
ASSETS
2008 2007
Unaudited
CURRENT ASSETS
Cash $5,177,061 $5,767,774
Accounts receivable, trade, net of
'/>"/>| SOURCE China Medicine Corporation Copyright©2008 PR Newswire. All rights reserved |